Clindamycin Phosphate Solution
Product Images NDC 45802-562

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Clindamycin Phosphate (NDC 45802-562). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

Chemical structure diagram of Clindamycin Phosphate showing atoms and bonds representing the molecular composition of the active ingredient.*

FDA Label Image

Image 02

Packaging label for Clindamycin Phosphate Topical Solution USP 1%, a 60 mL topical solution manufactured by Padagis Israel Pharmaceuticals Ltd. The label includes dosage strength, route of administration, storage instructions, directions for use, and Patient Information. The label also shows the product NDC 45802-562-02 and manufacturer details.*

FDA Label Image

Image 03

A product label panel for Clindamycin Phosphate topical solution 10 mg/mL featuring placeholder text for serial number, lot number, and expiration date fields within a bordered box. The label includes space to insert these specific product identifiers.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.